Scholar Rock Holding Corporation (SRRK)
NASDAQ: SRRK · Real-Time Price · USD
42.60
-1.61 (-3.64%)
At close: Mar 27, 2026, 4:00 PM EDT
42.99
+0.39 (0.92%)
After-hours: Mar 27, 2026, 4:38 PM EDT
Scholar Rock Holding Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
289
Market Cap
4.89B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 33.19M | 14.38M | 76.41% |
| Dec 31, 2021 | 18.82M | 3.41M | 22.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Caris Life Sciences | 812.03M |
| Amicus Therapeutics | 634.21M |
| TG Therapeutics | 616.29M |
| Mirum Pharmaceuticals | 521.31M |
| Rhythm Pharmaceuticals | 189.76M |
| Xenon Pharmaceuticals | 7.50M |
| CG Oncology | 4.04M |
| CRISPR Therapeutics AG | 3.51M |
SRRK News
- 1 day ago - Scholar Rock: From Manufacturing Hurdle To Commercial Muscle, Maintaining Buy Rating - Seeking Alpha
- 15 days ago - Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 17 days ago - Scholar Rock Holding Corporation (SRRK) Presents at Barclays 28th Annual Global Healthcare Conference Transcript - Seeking Alpha
- 25 days ago - Scholar Rock Holding Corporation (SRRK) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 25 days ago - CORRECTING and REPLACING Scholar Rock Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights - Business Wire
- 26 days ago - Scholar Rock Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights - Business Wire
- 5 weeks ago - Scholar Rock to Present at Upcoming Investor Conferences - Business Wire
- 6 weeks ago - Scholar Rock to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026 - Business Wire